A bioengineered model incorporating a synthetic extracellular matrix recapitulates the lymphoid tumour microenvironment, making it a valuable tool for drug testing and designing personalized therapies.
References
Hanahan, D. & Weinberg, R. A. Cell 144, 646–674 (2011).
Whiteside, T. L. Oncogene 27, 5904–5912 (2008).
Quail, D. F. & Joyce, J. A. Nat. Med. 19, 1423–1437 (2013).
Weiss, F., Lauffenburger, D. & Friedl, P. Nat. Rev. Cancer 22, 157–173 (2022).
Shah, B. S. et al. Nat. Mater. https://doi.org/10.1038/s41563-023-01495-3 (2023).
Schmitz, R. et al. N. Engl. J. Med. 378, 1396–1407 (2018).
Chapuy, B. et al. Nat. Med. 24, 679–690 (2018).
Lu, Y., Aimetti, A. A., Langer, R. & Gu, Z. Nat. Rev. Mater. 2, 16075 (2016).
Gu, L. & Mooney, D. J. Nat. Rev. Cancer 16, 56–66 (2016).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Gaharwar, A.K., Singh, I. A synthetic tumour microenvironment. Nat. Mater. 22, 412–413 (2023). https://doi.org/10.1038/s41563-023-01511-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41563-023-01511-6
- Springer Nature Limited